More than an immunosuppressant—lower serious infection rates with methotrexate in early rheumatoid arthritis

2025/06/26 by Shinji Izuka · 1 voice
Medicine · #Chronic Lymphocytic Leukemia Research #Hepatitis C virus research #Rheumatoid Arthritis Research and Therapies

paper · pdf · doi:10.1093/rheumatology/keaf354

openalex publication_date 2025/06/26 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Abstract

Shinji Izuka; More than an immunosuppressant—lower serious infection rates with methotrexate in early rheumatoid arthritis, Rheumatology, , keaf354, https:

Citations

• The immunology of rheumatoid arthritis

Discussions

• 🦠 Early methotrexate use was associated with a 24 % lower rate of serious infections in a UK early-RA cohort (Adas et al.). 📖 My editorial asks whether MTX’s immunomodulating—rather than purely imm [bsky, 1 points, 1 comments]

Related

• Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis
• Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based study
• Comparison of the efficacy and safety of methotrexate alone or in combination with leflunomide in the treatment of juvenile idiopathic arthritis: a double-blind, placebo-controlled, randomized trial
• Methotrexate Efficacy in the Tight Control in Psoriatic Arthritis Study
• Efficacy and Safety of CE-224,535, an Antagonist of P2X7Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate